Findings on Peptide Receptors Reported by Researchers at Veterans General Hospital (Erlotinib is effective in pancreatic cancer with epidermal growth factor receptor mutations: a randomized, open-label, prospective trial)

Source :: Biotech Week. December 30, 2015, 520
Publication Year :: 2015
Abstract: 2015 DEC 30 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- Fresh data on Membrane Proteins are presented in a new report. According to news reporting [...]

Subjects :: Analysis
Research
Pancreatic cancer -- Research -- Analysis
Veterans hospitals -- Analysis
Cancer research -- Analysis
Epidermal growth factors -- Analysis
Erlotinib -- Research -- Analysis
Membrane proteins -- Analysis

Tools